US Stock MarketDetailed Quotes

LLY Eli Lilly and Co

Watchlist
  • 767.760
  • +10.220+1.35%
Close Dec 20 16:00 ET
  • 780.990
  • +13.230+1.72%
Post 20:01 ET
728.85BMarket Cap83.00P/E (TTM)

About Eli Lilly and Co Company

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Company Profile

SymbolLLY
Company NameEli Lilly and Co
Listing DateApr 1, 1973
Founded1876
CEOMr. David A. Ricks
MarketNYSE
Employees43000
Fiscal Year Ends12-31
AddressLilly Corporate Center
CityIndianapolis
ProvinceIndiana
CountryUnited States of America
Zip Code46285
Phone1-317-276-2000
Websitehttp://www.lilly.com

Company Executives

  • Name
  • Position
  • Salary
  • David A. Ricks
  • Chairman of the Board, President and Chief Executive Officer
  • 26.57M
  • Dr. Daniel M. Skovronsky, M.D.
  • Executive Vice President, Chief Scientific Officer and President, Lilly Research Laboratories and Lilly Immunology
  • 11.85M
  • Lucas Montarce
  • Executive Vice President and Chief Financial Officer
  • --
  • Diogo Rau
  • Executive Vice President, Chief Information Officer and Chief Digital Officer
  • --
  • Donald A. Zakrowski
  • Senior Vice President, Finance and Chief Accounting Officer
  • --
  • Alonzo Weems
  • Executive Vice President, Enterprise Risk Management, Chief Ethics Officer and Compliance Officer
  • --
  • Anne E. White
  • Executive Vice President and President, Lilly Neuroscience
  • --
  • Patrik Jonsson
  • Executive Vice President and President, Lilly Diabetes and Obesity; President, Lilly USA
  • --
  • Eric Dozier
  • Executive Vice President, Human Resources and Diversity
  • --
  • Anat Hakim
  • Executive Vice President, General Counsel and Secretary
  • 7.01M
  • Ilya Yuffa
  • Executive Vice President and President, Lilly International
  • --
  • Johna L. Norton
  • Executive Vice President, Global Quality
  • --
  • Jacob S. Van Naarden
  • Executive Vice President and President, Loxo
  • 4.89M
  • Edgardo Hernandez
  • Executive Vice President and President, Manufacturing Operations
  • --
  • Juan R. Luciano
  • Lead Independent Director
  • 373.00K
  • Jon Erik Fyrwald
  • Independent Director
  • 344.88K
  • Karen Walker
  • Independent Director
  • 359.00K
  • Ralph Alvarez
  • Independent Director
  • 336.00K
  • Kimberly H. Johnson
  • Independent Director
  • 316.00K
  • Jamere Jackson
  • Independent Director
  • 345.00K
  • Jon R. Moeller
  • Independent Director
  • --
  • Dr. William G. Kaelin, Jr
  • Independent Director
  • 349.15K
  • Gabrielle Sulzberger, J.D.,M.B.A.
  • Independent Director
  • 335.50K
  • Dr. Mary Lynne Hedley,PhD
  • Independent Director
  • 319.00K
  • Katherine Baicker
  • Independent Director
  • 336.00K
Heat List
US
Overall
Symbol
Price
% Chg

No Data

Investment Theme Weight Loss Drugs
Weight Loss Drugs
Intraday-4.61%